Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Molecular Characterization and Treatment Approaches for Pediatric IH3 K27/I-Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant DataCancers, 2023-07, Vol.15 (13) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15133478Full text available |
|
2 |
Material Type: Article
|
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and ChallengesCancers, 2024-02, Vol.16 (4), p.794 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16040794 ;PMID: 38398185Full text available |
|
3 |
Material Type: Article
|
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and VaccinesCancers, 2024-01, Vol.16 (2), p.335 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16020335 ;PMID: 38254823Full text available |
|
4 |
Material Type: Article
|
Interpreting Randomized Controlled TrialsCancers, 2023-09, Vol.15 (19), p.4674 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15194674 ;PMID: 37835368Full text available |
|
5 |
Material Type: Article
|
Quality of Life and Independent Factors Associated with Poor Digestive Function after Ivor Lewis EsophagectomyCancers, 2023-11, Vol.15 (23), p.5569 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15235569 ;PMID: 38067274Full text available |
|
6 |
Material Type: Article
|
A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of ChinaCancers, 2023-08, Vol.15 (16), p.4060 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15164060 ;PMID: 37627088Full text available |
|
7 |
Material Type: Article
|
Role of Checkpoint Inhibitors in the Management of Gastroesophageal CancersCancers, 2023-08, Vol.15 (16), p.4099 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15164099 ;PMID: 37627127Full text available |
|
8 |
Material Type: Article
|
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue SarcomasCancers, 2023-10, Vol.15 (20), p.5036 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15205036 ;PMID: 37894403Full text available |
|
9 |
Material Type: Article
|
Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?Cancers, 2023-08, Vol.15 (17), p.4262 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15174262 ;PMID: 37686537Full text available |
|
10 |
Material Type: Article
|
Belantamab Mafodotin: From Clinical Trials Data to Real-Life ExperiencesCancers, 2023-05, Vol.15 (11), p.2948 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15112948 ;PMID: 37296910Full text available |
|
11 |
Material Type: Article
|
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)Cancers, 2023-08, Vol.15 (16), p.4028 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15164028 ;PMID: 37627056Full text available |
|
12 |
Material Type: Article
|
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature ReviewCancers, 2023-04, Vol.15 (9), p.2561 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15092561 ;PMID: 37174027Full text available |
|
13 |
Material Type: Article
|
Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting CellsCancers, 2023-07, Vol.15 (14), p.3627 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15143627 ;PMID: 37509288Full text available |
|
14 |
Material Type: Article
|
Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future PerspectivesCancers, 2023-03, Vol.15 (7), p.2074 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15072074 ;PMID: 37046734Full text available |
|
15 |
Material Type: Article
|
Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical TrialCancers, 2023-05, Vol.15 (10), p.2809 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15102809 ;PMID: 37345146Full text available |
|
16 |
Material Type: Article
|
Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II TrialCancers, 2023-04, Vol.15 (9), p.2543 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15092543 ;PMID: 37174008Full text available |
|
17 |
Material Type: Article
|
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)Cancers, 2023-04, Vol.15 (9), p.2441 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15092441 ;PMID: 37173908Full text available |
|
18 |
Material Type: Article
|
Six-Month Prostate Cancer Empowerment Program (PC-PEP) Improves Urinary Function: A Randomized TrialCancers, 2024-02, Vol.16 (5), p.958 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. 2024 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16050958 ;PMID: 38473319Full text available |
|
19 |
Material Type: Article
|
Leveraging Programmatic Collaboration for a Radiopharmaceutical ClinicCancers, 2024-04, Vol.16 (7), p.1396 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16071396 ;PMID: 38611074Full text available |
|
20 |
Material Type: Article
|
Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis ModelCancers, 2024-04, Vol.16 (7), p.1360 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16071360 ;PMID: 38611037Full text available |